BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 19956058)

  • 21. Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients.
    Julia F; Dalle S; Duru G; Balme B; Vergier B; Ortonne N; Vignon-Pennamen MD; Costes-Martineau V; Lamant L; Dalac S; Delattre C; Déchelotte P; Courville P; Carlotti A; De Muret A; Fraitag S; Levy A; Mitchell A; Petrella T
    Am J Surg Pathol; 2014 May; 38(5):673-80. PubMed ID: 24441662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
    Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
    Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.
    Julia F; Petrella T; Beylot-Barry M; Bagot M; Lipsker D; Machet L; Joly P; Dereure O; Wetterwald M; d'Incan M; Grange F; Cornillon J; Tertian G; Maubec E; Saiag P; Barete S; Templier I; Aubin F; Dalle S
    Br J Dermatol; 2013 Sep; 169(3):579-86. PubMed ID: 23646868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
    Paluri R; Nabell L; Borak S; Peker D
    Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells.
    Jacob MC; Chaperot L; Mossuz P; Feuillard J; Valensi F; Leroux D; Béné MC; Bensa JC; Brière F; Plumas J
    Haematologica; 2003 Aug; 88(8):941-55. PubMed ID: 12935983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A CD56- immunoblastoid variant of blastic plasmacytoid dendritic cell neoplasm.
    Aran BM; Duran J; Whittemore D; Gru AA
    J Cutan Pathol; 2024 Jan; 51(1):40-44. PubMed ID: 37612885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
    Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
    Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression.
    Tang H; Panse G; Braddock D; Perincheri S; Xu ML; McNiff JM
    J Cutan Pathol; 2023 Jul; 50(7):595-600. PubMed ID: 37082914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-interferon secreting blastic plasmacytoid dendritic cells neoplasm: a case report with histological, molecular genetics and long-term tumor cells culture studies.
    Petrella T; Hervé G; Bonnotte B; Girodon F; Carlson JA; Bour JB; Lebon P; Mugneret F; Callier P
    Am J Dermatopathol; 2012 Aug; 34(6):626-31. PubMed ID: 22534638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement.
    Gera S; Dekmezian MS; Duvic M; Tschen JA; Vega F; Cho-Vega JH
    Am J Dermatopathol; 2014 Mar; 36(3):244-51. PubMed ID: 24247574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid dendritic cell neoplasm.
    Hashikawa K; Niino D; Yasumoto S; Nakama T; Kiyasu J; Sato K; Kimura Y; Takeuchi M; Sugita Y; Hashimoto T; Ohshima K
    J Am Acad Dermatol; 2012 Feb; 66(2):278-91. PubMed ID: 21835496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?
    Dalle S; Beylot-Barry M; Bagot M; Lipsker D; Machet L; Joly P; Dompmartin A; d'Incan M; Maubec E; Grange F; Dereure O; Prey S; Barete S; Wetterwald M; Fraitag S; Petrella T
    Br J Dermatol; 2010 Jan; 162(1):74-9. PubMed ID: 19689477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study of 7 cases].
    Xiong J; Chen H; Zhang M; Zheng Y; Qiao J; Sheng N; Xu X; Sun J
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(8):599-602. PubMed ID: 24762690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early plasmacytoid dendritic cell leukemia/lymphoma coexpressing myeloid antigenes.
    Giagounidis AA; Heinsch M; Haase S; Aul C
    Ann Hematol; 2004 Nov; 83(11):716-21. PubMed ID: 15316755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomorphological features of blastic plasmacytoid dendritic cell neoplasm on FNA and cerebrospinal fluid cytology: A review of 6 cases.
    Ferreira J; Gasparinho MG; Fonseca R
    Cancer Cytopathol; 2016 Mar; 124(3):196-202. PubMed ID: 26618304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The morphologic spectrum of primary cutaneous anaplastic large T-cell lymphoma: a histopathologic study on 66 biopsy specimens from 47 patients with report of rare variants.
    Massone C; El-Shabrawi-Caelen L; Kerl H; Cerroni L
    J Cutan Pathol; 2008 Jan; 35(1):46-53. PubMed ID: 18095994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ
    Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical presentation of blastic plasmacytoid dendritic cell neoplasm: A potential diagnostic pitfall in nasal cavity.
    Yu F; Sun K; Wang Z
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Oct; 126(4):e212-e214. PubMed ID: 29884520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells.
    Gopcsa L; Banyai A; Jakab K; Kormos L; Tamaska J; Matolcsy A; Gogolak P; Rajnavolgyi E; Paloczi K
    Eur J Haematol; 2005 Oct; 75(4):346-51. PubMed ID: 16146542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.